Showing 61 - 80 of 132 results
This program explores the mechanism and outcome of the interaction of radiation on biological systems in order to improve our understanding of the impact of radiation on the brain, optimise radiotherapy and develop mitigation strategies for space travellers.
The ANSTO Awards in Nuclear Science and Technology 2018 were presented on Friday 2 November at The Australian Museum, and showcased ANSTO’s unique nuclear science and technology capabilities, which enable progress in the key areas of health research and innovation for industry.
Hudson Institute of Medical Research and Monash University researchers used synchrotron X-rays produce powerful visualisation of video of changes to blood flow to brain during ventilation in large preterm clinical models.
On 20 July 1969, humans landed on the moon for the very first time. As Neil Armstrong was lowered onto the surface of the moon he made the now infamous statement, “That's one small step for man, one giant leap for mankind”.
Collaboration investigates a promising new nanoparticle for potential use in combination with other therapies for brain cancer
The project aims to engage the wider cultural heritage community in addition to our internal research.
Micro radiation therapy being developed by UOW in association with the Australian Synchrotron.
ANSTO physicist will gain further experience in particle therapy technologies.
A world-class national research facility that uses accelerator technology to produce a powerful source of light-X rays and infrared radiation a million times brighter than the sun.
This state-of-the-art metastable-exchange optical-pumping helium-3 polarising system enables polarisation-analysis experiments on five of our existing instruments.
Director of the Australian Synchrotron Prof Andrew Peele has been appointed to Australian Mathematical Sciences Board.
ANSTO health researchers have contributed to an international study published in Nature Neuroscience that sheds light on the mechanism by which anti-anxiety drugs act on the brain which could lead to cognitive impairment in vulnerable individuals.
An ANSTO radiochemist has been awarded a scholarship to carry out research at the world-renowned Sloan Kettering Cancer Center in New York.